follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

PCT, ImmunoCellular announce manufacturing partnership

By

Back to Top Comments Email Print

Latest News

    advertisement

    New York-based NeoStem Inc.; its Allendale-based subsidiary, Progenitor Cell Therapy LLC; and ImmunoCellular Therapeutics Ltd., of Los Angeles, a clinical-stage biotechnology company developing cancer therapies, announced today PCT will provide manufacturing services to support research and development of an ImmunoCellular drug candidate.

    Financial terms were not disclosed. PCT provides manufacturing services for ImmunoCellular's lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma.

    Share This Story On:

    Write to the Editorial Department at editorial@njbiz.com

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top